CDx Diagnostics

About:

CDx Diagnostics develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells.

Website: https://www.cdxdiagnostics.com/

Twitter/X: cdxdiagnostics

Description:

CDx develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells. It offers OralCDx, an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer, prevention of cancer of the oral cavity, pharynx, larynx, and esophagus through early detection of their easily treatable and pre-cancerous precursors. It provides these tests and systems nationally to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.

Total Funding Amount:

$11M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Suffern, New York, United States

Founded Date:

1997-01-01

Contact Email:

support(AT)cannablisslabs.com

Founders:

Drore Eisen, Mark Rutenberg, William Huffnagle

Number of Employees:

101-250

Last Funding Date:

2019-12-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai